We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
Cap. Flow
+$505M
Cap. Flow %
0.65%
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$83.5M
2
SPGI icon
S&P Global
SPGI
+$73.5M
3
TSLA icon
Tesla
TSLA
+$55.8M
4
MSFT icon
Microsoft
MSFT
+$45.9M
5
AMZN icon
Amazon
AMZN
+$27.9M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$88.8M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$74.7M
3
CONE
CyrusOne Inc Common Stock
CONE
+$31.7M
4
ABT icon
Abbott
ABT
+$25.5M
5
EXC icon
Exelon
EXC
+$23.2M

Sector Composition

Rank Sector Weight
1 Technology 24.74%
2 Financials 13.53%
3 Healthcare 13.01%
4 Consumer Discretionary 11.66%
5 Industrials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOLT icon
2951
Bolt Biotherapeutics
BOLT
$7.78M
$65K ﹤0.01%
1,183
+120
+11% +$8.08K
PLSE icon
2952
Pulse Biosciences
PLSE
$3.02B
$65K ﹤0.01%
13,340
-301
-2% -$2.46K
TIG
2953
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$65K ﹤0.01%
13,790
-2,302
-14% -$15.5K
HOFV
2954
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$64K ﹤0.01%
2,617
+302
+13% +$7.77K
STON
2955
DELISTED
StoneMor Inc.
STON
$63K ﹤0.01%
24,044
-3,365
-12% -$8.66K
RVI
2956
DELISTED
Retail Value Inc. Common Shares
RVI
$62K ﹤0.01%
20,212
-25,592
-56% -$80.8K
CDZI icon
2957
Cadiz
CDZI
$291M
$61K ﹤0.01%
29,369
-796
-3% -$2K
TECX
2958
Tectonic Therapeutic
TECX
$606M
$61K ﹤0.01%
3,882
-390
-9% -$8.06K
KLTR icon
2959
Kaltura
KLTR
$267M
$60K ﹤0.01%
33,485
+21,415
+177% +$58.8K
BMEA icon
2960
Biomea Fusion
BMEA
$91.3M
$59K ﹤0.01%
+13,190
New +$85.6K
NEXI
2961
DELISTED
NexImmune, Inc. Common Stock
NEXI
$59K ﹤0.01%
560
+159
+40% +$11.7K
MFG icon
2962
Mizuho Financial
MFG
$130B
$58K ﹤0.01%
22,650
+245
+1% +$671
STIM icon
2963
Neuronetics
STIM
$166M
$58K ﹤0.01%
19,248
+559
+3% +$1.89K
RAIN
2964
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$57K ﹤0.01%
11,319
+725
+7% +$5.81K
RTB
2965
RTB Digital
RTB
$232M
$56K ﹤0.01%
+38
New +$47.5K
ATER icon
2966
Aterian
ATER
$5.37M
$55K ﹤0.01%
1,896
+517
+37% +$18.9K
INZY
2967
DELISTED
Inozyme Pharma
INZY
$53K ﹤0.01%
12,890
-174
-1% -$1.02K
VINC
2968
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$53K ﹤0.01%
+665
New +$82.1K
ERNA icon
2969
Eterna Therapeutics
ERNA
$4.91M
$52K ﹤0.01%
3
+1
+50% +$19K
PAYO icon
2970
Payoneer
PAYO
$2.41B
$52K ﹤0.01%
11,624
– –
FFAI
2971
Faraday Future Intelligent Electric
FFAI
$10.5M
– –
0
– –
AXDX
2972
DELISTED
Accelerate Diagnostics
AXDX
$51K ﹤0.01%
3,576
-68
-2% -$1.94K
SEEL
2973
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$50K ﹤0.01%
16
+1
+7% +$4.3K
MKTW icon
2974
MarketWise
MKTW
$56.6M
$48K ﹤0.01%
504
– –
EMWP
2975
DELISTED
Eros Media World PLC
EMWP
$48K ﹤0.01%
17,215
+78
+0.5% +$325
117 118
119
120 121

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
  • RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
  • RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
  • RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
  • RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
  • RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.